HOUSTON, TX, May 1, 2013 — eCardio Diagnostics (www.ecardio.com), a leader in remote arrhythmia monitoring services, today announced the launch of eCardio Verité – a patient-friendly, wireless monitor offering seamless transition between mobile cardiac telemetry and cardiac event monitoring when directed by a physician.
“We are excited to provide physicians with the innovative new choice in mobile cardiac telemetry through the launch of this monitor,” said eCardio’s President and Chief Executive Officer, Larry Lawson. “With remote programming functionality and built-in symptom and activity capture, eCardio Verité provides physicians with the monitoring services needed to make an accurate arrhythmia diagnosis as quickly as possible.”
eCardio Verité is a multi-functional monitor with both event and telemetry monitoring capabilities, including automatic detection, capturing and communication of asymptomatic events such as Atrial Fibrillation, Bradycardia, Tachycardia and Cardiac Pause. A remotely programmable feature of eCardio Verité allows eCardio’s monitoring center to seamlessly transition the monitor from a telemetry monitor to an event monitor when directed by a patient’s physician without any disruption to a patient’s monitoring study.
Physicians prescribing eCardio Verité will experience additional benefits through both enhancements to existing reports and a newly developed report, the Verité Initial Assessment. The Verité Initial Assessment is provided for the first 24 hours of monitoring and may alleviate the need for preliminary Holter studies.
“Our new reports for eCardio Verité reflect what physicians have told us is desired to provide optimal care to their patients,” said Lawson. “Our nationwide cardiology sales force spends time in practices every day, and those conversations played an integral part in the development of the reports we provide with this new monitor.”
The enhanced reports highlight the data output from the monitor’s advanced algorithm and also provide the data in organized snapshots that include a daily summary, a five-day summary, and a full-study summary of each arrhythmia by type and by date.
To view the new reports and see a demonstration of eCardio Verité, visit Booth #1930 at Heart Rhythm 2013 in Denver, May 8-10, 2013.
eCardio has provided remote cardiac monitoring services since 2004 and provided monitoring through mobile cardiac telemetry for nearly two years. For more information about eCardio Verité, please visit www.ecardio.com.
eCardio Diagnostics, LLC, www.ecardio.com, is one of the nation’s leading providers of comprehensive and advanced technologies, devices, services and solutions for the diagnosis, monitoring and subsequent clinical management of cardiac arrhythmias, predominantly in an ambulatory setting. eCardio provides leading-edge diagnostic innovations and solutions that optimize the flexibility, speed and accuracy of cardiac arrhythmia diagnoses.